Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Classification of Diabetic Nephropathy 2014].
Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, Kimura K, Suzuki Y, Wada T, Ogawa S, Inaba M, Kanno Y, Shigematsu T, Masakane I, Tsuchiya K, Honda K, Ichikawa K, Shide K; Joint Committee on Diabetes Nephropathy; Japanese Diabetes Society; Japanese Society of Nephrology; Japanese Society for Dialysis Therapy; Japan Society of Metabolism and Clinical Nutrition. Haneda M, et al. Among authors: inaba m. Nihon Jinzo Gakkai Shi. 2014;56(5):547-52. Nihon Jinzo Gakkai Shi. 2014. PMID: 25130030 Review. Japanese.
A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.
Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, Makino H, Kimura K, Suzuki Y, Wada T, Ogawa S, Inaba M, Kanno Y, Shigematsu T, Masakane I, Tsuchiya K, Honda K, Ichikawa K, Shide K; Joint Committee on Diabetic Nephropathy. Haneda M, et al. Among authors: inaba m. J Diabetes Investig. 2015 Mar;6(2):242-6. doi: 10.1111/jdi.12319. Epub 2015 Mar 1. J Diabetes Investig. 2015. PMID: 25802733 Free PMC article.
Best practice for diabetic patients on hemodialysis 2012.
Nakao T, Inaba M, Abe M, Kaizu K, Shima K, Babazono T, Tomo T, Hirakata H, Akizawa T; Japanese Society for Dialysis Therapy. Nakao T, et al. Among authors: inaba m. Ther Apher Dial. 2015 Mar;19 Suppl 1:40-66. doi: 10.1111/1744-9987.12299. Ther Apher Dial. 2015. PMID: 25817932 No abstract available.
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators. Kimura K, et al. Among authors: inaba m. Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1. Am J Kidney Dis. 2018. PMID: 30177485 Free article. Clinical Trial.
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.
Hosoya T, Kimura K, Itoh S, Inaba M, Uchida S, Tomino Y, Makino H, Matsuo S, Yamamoto T, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H. Hosoya T, et al. Among authors: inaba m. Trials. 2014 Jan 16;15:26. doi: 10.1186/1745-6215-15-26. Trials. 2014. PMID: 24433285 Free PMC article. Clinical Trial.
Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?
Abe M, Hamano T, Hoshino J, Wada A, Inaba M, Nakai S, Masakane I. Abe M, et al. Among authors: inaba m. Diabetes Res Clin Pract. 2017 Aug;130:211-220. doi: 10.1016/j.diabres.2017.06.012. Epub 2017 Jun 13. Diabetes Res Clin Pract. 2017. PMID: 28648854
An introduction to CKD-MBD research: restart for the future.
Fukagawa M, Inaba M, Yokoyama K, Shigematsu T, Ando R, Miyamoto KI; For Japan CKD-MBD Forum. Fukagawa M, et al. Among authors: inaba m. Clin Exp Nephrol. 2017 Mar;21(Suppl 1):1-3. doi: 10.1007/s10157-016-1372-7. Clin Exp Nephrol. 2017. PMID: 28083765 No abstract available.
1,559 results